Research Work

1. TVT Continence Surgery in Treating Female SUI – 1st 100 cases.
2. TVT Continence Surgery in Treating Female SUI (189 cases) – 6-month & 1 year follow-up.
3. TVT Continence Surgery in treating women SUI (318 cases) – 6 months to 3 years follow-up
4. TVT Continence Surgery in Treating Women SUI (371 cases) – up to 3 years follow-up.
5. The Success Rate of Burch Colposuspension and Its Impact on the Quality of Life and Pelvic Organ Prolapse – up to 3 years follow-up.
6. The Pelvic Floor Muscle Exercises in hospital women.
7. Peri-operative Complications of Burch Colposuspension at the Urogynaecology Centre, KK Hospital.
8. Comparison Between Sacrocolpopexy and Sacrospinous Vault Suspension in Treating Women with Severe
Uterovaginal Prolapse or Vault Prolapse.
9. A review of 500 cases of vaginal hysterectomy.
10. The place of local anaesthesia in vaginal hysterectomy.
11. Two case reports on patients with recurrent urinary tract infection.
12. Case report on arresting bleeding pedicles after vaginal hysterectomy.
13. TVT continence surgery in treating women SUI – A review of 500 cases.
14. Randomised study on the use of gynemesh in severe cystourethrocele repair.
15. The use of 3-Dimensional Ultrasound scan to assess the clinical importance of midurethral placement of the
Tension-free Vaginal Tape (TVT) in its treatment of incontinence.
16. Survey on General Practitioners Knowledge on Female Urinary Incontinence and Pelvic Organ Prolapse.
17. A case report on Burch Colposuspension complicated by broken suture needle.
18. A review on the safety and the effectiveness of sacrospinous ligament fixation in treating vault prolapse.
19. A review on the case of prolene mesh in treating severe cystourethrocele.
20. Early experience on the use of gynemesh in treating severe and recurrent cystourethrocele (44 cases).
21. Early experience on the TVT-O in treating women stress urinary incontinence (26 cases).
22. One-year follow-up on gynemesh in treating severe and recurrent cystourethrocele (44 cases).
23. 6 months follow-up on TVT-O in treating women stress urinary incontinence (98 cases).
24. 6 months follow-up on gynemesh in treating severe and recurrent cystourethrocele (95 cases).
25. Retrospective review of 50 cases of TVT-O vs TVT in treating women stress urinary incontinence.
26. A Clinical Evaluation for the Gynecare TVT-obturator system for Treatment of Stress Urinary Incontinence.
27. Comparing Tension-free Vaginal Tape (TVT) & TVT-Obturator (TVT-O) in the surgical management of Female
Stress Urinary Incontinence.
28. Case report on releasing of Transobturator (tension-free) vaginal tape 3 weeks post-operatively for urinary
retention.
29. Case report on multiple complications of Tension-free Vaginal tape (TVT).
30. Sacrospinous Ligament Fixation: six months follow-up on 332 patients.
31. Sacrospinous ligament Fixation (SSF) and pelvic floor repair (6 months & 1-year follow-up): A Retrospective Study.
32. A retrospective study on Sacrospinous ligament fixation- 6 months & 18 months follow-up.
33. Tension-free Vaginal Tape Obturator (TVT-O) in management of female Stress Urinary Incontinenc  (SUI).
34. Cost Effective Screening for Urinary Tract Infection (UTI) in Urogynaecological patients.
35. Long term follow-up of patients undergoing the tension-free vaginal tape (TVT) procedure.
36. Risk of recurrent cystourethrocele following Sacrospinous Ligament Fixation-6 months & 1-year follow-up.
37. Retrospective analysis of patients with Sacrospinous Ligament Fixation complicated by erosion/extrusion.
38. The outcome of surgical management of severe anterior vaginal wall prolapse.
39. The outcome of cystocele repair.
40. The Use of Prolift in the surgical treatment of pelvic organ prolapse.
41. Case report on pelvic haematoma.
42. A retrospective study on the use of TVT Secur in the surgical management of female stress urinary incontinence.
43. Role of outpatient bedside ultrasound evaluation of hydronephrosis in severe uterovaginal / vault prolapse.
44. Retrospective study on intravesical Dimethylsulfoxide (DMSO) in treatment of the painful bladder.
45. Prospective study of POP-Q measurement with and without using SIMS speculum.
46. Case report: Development of Asherman’s Syndrome after myomectomy.
47. Retrospective study on TVT-O.
48. Case report: Endometriosis of Urinary Bladder.
49. Risk of recurrent cystourethrocele in patients without SSF.
50. Is 24 hours enough? – Duration of bladder catheterisation after anterior vaginal wall repair.
51. TVT Secur :  Secure or Insecure?
52. TVT-World-Wide Observational Registry for Long-Term Data. Protocol number: 300-06-006
53. 12-Week, Randomized, Double-blind, Double-dummy, Placebo-controlled, parallel-group, Multicenter trial to evaluate the efficacy and safety of Fesoterodine in comparison to Tolterodine ER in patients with overactive bladder. Protocol number: A0221008
54. Retrospective analysis of Patients with TVT/ TVT-O complicated by Mesh erosion.
55. 18 months follow-up on patients who underwent tension-free vaginal tape-Obturator (TVT-O)
56. A comprehensive review of patients who underwent TVT procedure with or without concurrent surgery in the treatment of urinary incontinence.
57. Retrospective review on vaginal hysterectomy in urogynaecology center.
58. Comparison of urethral pressure profiles between pre and post tension-free vaginal tape (TVT) operation.
59. Role of urethral pressure profile in predicting outcome of TVT/TVT-O continent procedures.
60. Incidence of hydronephrosis in severe uterovaginal and/or vault prolapse.
61. Role of outpatient bedside ultrasound evaluation of hydronephrosis in severe Uterovaginal and/or vault prolapse.
62. Retrospective study on the safety and efficacy of Gynecare Prolift* in the surgical treatment of pelvic organ prolapse: A 6 months Follow-up.
63. Case report on bladder injury during tension free vaginal tape Secur (TVT-S).
64. Surgical management of recurrent stress urinary incontinence after primary continence surgery.
65. Secondary Mid-Urethral Sling (MUS) surgery in previous failed continence surgery; KK Hospital’s Initial Experience.
66. Outcomes of Intravesical Dimethylsulfoxide (DMSO) in treatment of painful bladder syndrome.
67. 12-Week, Randomized, Double-blind, Double-dummy, Placebo-controlled, parallel-group, Multicenter trial to evaluate the efficacy and safety of Fesoterodine in comparison to Tolterodine ER in patients with overactive bladder. Protocol number: A0221046
68. A Clinical Evaluation of the Gynecare TVT Obturator System for treatment of Stress Urinary Incontinence (Protocol no: 300-04-004) (C)
69. The use of Prolift in the surgical treatment of pelvic organ prolapse.
70. Tension-free vaginal tape-obturator (TVT-O) for the treatment of female stress urinary incontinence: 1 year follow-up.
71. 3D/4D ultrasound of Tension-free Vaginal Tape-SECUR and Tension-Free Vaginal Tape-Obturator in the same patient.
72. 3D/4D ultrasound on 5 patients with Tension-free Vaginal Tape-SECUR.
73. A retrospective study on the use of TVT-O for female stress urinary incontinence management a three-year follow-up.
74. The adjustable TVT-O
75. The Use of Gynaecare Prolift® in the surgical treatment of Pelvic Organ Prolapse
76. Secondary Mid-Urethral Sling (MUS) Surgery in Previous Failed Continence Surgery; KK Hospital’s Initial Experience.
77. TVT-Worldwide Observational Registry for Long-term Data (Protocol: 300-06-006).
78. A retrospective study on the use of TVT Secure in the surgical management of female stress urinary in continence.
79. Use of the Gynecare Prolift® system in surgery for pelvic organ prolapse: 1-year outcome
80. Retrospective study of transobturator polypropylene mesh kit for management of pelvic organ prolapse
81. Retrospective study on Tension-Vaginal Tape-Obturator (TVT-O)
82. Effect of varying body mass index (BMI) on tension free vaginal tape obturator (TVT-O) – outcome and complications.
83. Retrospective review of TVT Secure in treating female stress urinary incontinence.
84. 2 case reports of voiding disorder secondary to cancer of the vagina.
85. Case report on recurrent goretex mesh erosion in a patient after abdominal sacrocolpopexy with final spontaneous expulsion of the mesh vaginally.
86. Risk factor assessment after mid-urethral sling surgery for SUI at 1 year
87. A retrospective review of patients who underwent Tension-free vaginal tape (TVT) – A 5 years review
88. How long is enough? – Duration of indwelling catheter after vaginal surgery.
89. Evaluating the three year’s peri-operative outcome post Gynecare Prolift® System in pelvic organ prolapse (POP) surgeries performed in 2006 at the KKWCH Hospital.
90. The surgical treatment of pelvic organ prolapse (6 months and 1 year follow-up)
91. A 3-year outcome following sacrospinous ligament fixation in the treatment of mild and severe apical support : a single-surgeon experience
92. A retrospective study on patients who underwent prolift procedure from 2006-2008 (4, 3 and 2 years follow-up)
93. Retrospective (1 year) study on patients who underwent prolift procedure in 2009
94. Sacrospinous ligament fixation versus Gynecare Prolift® system: A comparison in a 3-year outcome of surgical management for advance (grade 3 and 4) apical prolapse.
95. Evaluation of the significance of asymptomatic microscopic hematuria: a retrospective study over a one-year period.
96. Can demonstrable stress urinary incontinence during filling and voiding cystometry predict a low urethral pressure profile?
97. Initial experience with TVT-Abbrevo at a tertiary care hospital.
98. Retrospective comparative study of 5 year outcome for Tension free Vaginal Tape (TVT) and Tension free Vaginal Tape-Obturator (TVT-O) for female stress urinary incontinence